AbbVie Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
AbbVie Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2012 to Q3 2024.
  • AbbVie Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $520M, a 202% increase year-over-year.
  • AbbVie Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $2.06B, a 39.3% increase year-over-year.
  • AbbVie Inc. annual Income Tax Expense (Benefit) for 2023 was $1.38B, a 15.6% decline from 2022.
  • AbbVie Inc. annual Income Tax Expense (Benefit) for 2022 was $1.63B, a 13.3% increase from 2021.
  • AbbVie Inc. annual Income Tax Expense (Benefit) for 2021 was $1.44B.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.06B $520M +$348M +202% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $1.72B $773M +$190M +32.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $1.53B $383M +$149M +63.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $1.38B $388M -$105M -21.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 $1.48B $172M -$276M -61.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 $1.76B $583M +$328M +129% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $1.43B $234M -$202M -46.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 $1.63B $493M +$267M +118% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 $1.37B $448M -$60M -11.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $1.43B $255M -$139M -35.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $1.56B $436M +$124M +39.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $1.44B $226M +$1.77B Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 -$331M $508M +$321M +172% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 -$652M $394M +$348M +757% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$1B $312M +$224M +255% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 -$1.22B -$1.55B -$1.82B -666% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-17
Q3 2020 $594M $187M +$70M +59.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $524M $46M -$20M -30.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-02
Q1 2020 $544M $88M $0 0% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $544M $273M +$820M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-18
Q3 2019 -$276M $117M +$103M +736% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 -$379M $66M +$37M +128% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 -$416M $88M +$74M +529% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 -$490M -$547M -$1.69B -148% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-19
Q3 2018 $1.2B $14M -$450M -97% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $1.65B $29M -$409M -93.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 $2.06B $14M -$361M -96.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
Q4 2017 $2.42B $1.14B +$534M +88% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q3 2017 $1.88B $464M +$48M +11.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $1.84B $438M -$48M -9.88% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $1.88B $375M -$47M -11.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $1.93B $607M +$200M +49.1% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $1.73B $416M +$8M +1.96% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $1.72B $486M +$174M +55.8% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $1.55B $422M +$48M +12.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $1.5B $407M +$634M Oct 1, 2015 Dec 31, 2015 10-K 2018-02-16
Q3 2015 $867M $408M +$227M +125% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $640M $312M -$23M -6.87% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $663M $374M +$68M +22.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $595M -$227M -$538M -173% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-17
Q3 2014 $1.13B $181M -$141M -43.8% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $1.27B $335M +$35M +11.7% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $1.24B $306M +$35M +12.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $1.2B $311M +$138M +79.8% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-19
Q3 2013 $1.07B $322M +$303M +1595% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $763M $300M +$165M +122% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $598M $271M +$148M +120% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 $450M $173M Oct 1, 2012 Dec 31, 2012 10-K 2015-02-20
Q3 2012 $19M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $135M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 $123M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.